Summary
Background & aims
Previous
epidemiological studies have provided inconsistent conclusions on the
impact of coffee consumption in the developing of cognitive disorders.
However, no previous meta-analysis has pooled the evidence from the
prospective cohort studies to assess the influence of coffee drinking
and its potential dose-response patterns on the risk of developing
cognitive disorders specifically.
Methods
Two
databases (PubMed and Embase) were searched for evidence of cohort
studies from inception to February 2016. We used a generic
inverse-variance method with a random-effects model to pool the fully
adjusted relative risks (RRs) and the corresponding 95% confidence
intervals (CIs). In the dose-response analyses, a generalized
least-squares trend estimation model was applied to computing the
study-specific slopes.
Results
Nine
prospective cohort studies involving 34,282 participants were included
in our study. The duration of follow-up years ranged from 1.3 to 28.
Compared with <1 cup, daily drinking of 1-2 cups of coffee was
inversely linked with the occurrence of cognitive disorders (i.e.,
Alzheimer’s disease, dementia, cognitive decline, and cognitive
impairment), and the pooled RR (95% CI) was 0.82 (0.71, 0.94) with
evidence of non-significant heterogeneity (I2=25%).
Non-significant differences were presented for the association between
coffee consumption (>3 vs. <1 cup/d) and incident cognitive
disorders. The dose-response analysis showed a “J-shaped” curve
relationship of the risk of developing cognitive disorders with coffee
consumption.
Conclusions
A “J-shaped”
association was presented between coffee intake and incident cognitive
disorders, with the lowest risk of incident cognitive disorders at a
daily consumption level of 1-2 cups of coffee.
No comments:
Post a Comment